Clinical trial
Intermittent Levetricetam in Treatment of Febrile Convulsions
NCT05860153 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermittent Levetricetam in Treatment of Febrile Convulsions
- Lead sponsor
- Assiut University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 1, 2023
- Completion date
- August 1, 2024
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
febrile convulsion